J. Hayungs

Phase I/II study with a weekly 24-hour infusion of 5-fluorouracil plus high-dose folinic acid (HD-FU/FA) in intensively pretreated patients with metastatic breast cancer.

U. Vanhoefer, S. Seeber, R. Becher, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase-II study of low-dose cyclophosphamide and recombinant human interleukin-2 in metastatic renal cell carcinoma and malignant melanoma

V. Diehl, F. Herrmann, J. Kolitz, 2004, Cancer Immunology, Immunotherapy.

A multicenter trial of interleukin-2 and low-dose cyclophosphamide in highly chemotherapy-resistant malignancies.

V. Diehl, M. Boehm, R. Schmidt, 1989, Cancer treatment reviews.

Treatment of high-risk, nonseminomatous testicular cancer with cisplatin, ifosfamide and bleomycin: long-term results.

S. Seeber, M. Scheulen, N. Niederle, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognosis and treatment of disseminated uveal melanoma

N. Bornfeld, S. Seeber, K. Höffken, 1993, Cancer.

Primary gastric non-Hodgkin's lymphoma: a clinicopathological study of 41 patients

K. Donhuijsen, S. Seeber, K. Höffken, 2005, Journal of Cancer Research and Clinical Oncology.

Epirubicin and ifosfamide in metastatic breast cancer.

S. Seeber, S. Halabi, R. Becher, 1996, Seminars in Oncology.